Skip to content

Eli Lilly LLY Net Change in Cash

Net Change in Cash at other companies

Pfizer logo
PfizerPFE
$563M+50.1%
Amgen logo
AmgenAMGN
$2.91B+192%
Cardinal Health logo
Cardinal HealthCAH
$1.16B+340%
Mannkind logo
MannkindMNKD
-$22.05M-2,361%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.59M-88.2%
McKesson logo
McKessonMCK
-$1.06B+14.1%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.08T+54.2%
Enterprise value$1.12T+51.7%
P/E42.6×-8.0×
P/S14.9×+1.8×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's net change in cash?
Eli Lilly (LLY) reported net change in cash of -$1.99B in Q1 2026.
How has Eli Lilly's net change in cash changed year-over-year?
Eli Lilly's net change in cash decreased by 1034.9% year-over-year, from -$175M to -$1.99B.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.